CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -17.4% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -562.9% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -580.3% | – |
| EPS Diluted | -1.04 | -1.77 | -0.99 | -0.88 |
| % Growth | 41.2% | -78.8% | -12.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |